Partner Antoinette Konski and Associate Simon Elliott authored, “Induced Pluripotent Stem Cells: A U.S. Patent Landscape Analysis,” published in the May 14, 2013 edition of Genetic Engineering and Biotechnology News. The article provides a discussion of the U.S. patent landscape for induced pluripotent stem cells (iPSCs) and identifies key technologies and institutions that are leading research and development in the creation and use of iPSCs.
The article also was referenced in a May 14, 2013 piece in the Boston Business Journal, which discussed the growth in the number of iPSCs patents held by Cambridge-area companies.
Click here to read the entire article.
Author(s)
Related Insights
December 19, 2025
Health Care Law Today
Gender Affirming Care for Minors: CMS and HHS Propose Limits on “Sex Rejection Procedures” and Expanded Enforcement Pathways
On December 18, 2025, the U.S. Department of Health and Human Services (HHS) held a press conference focused on what is defined as “sex…
December 19, 2025
Foley Viewpoints
Prohibition to Prescription: What Trump’s Marijuana Executive Order Really Means
On December 18, 2025, President Donald Trump issued an Executive Order, Increasing Medical Marijuana and Cannabidiol Research, that…
December 18, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…